<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="335243">
  <stage>Registered</stage>
  <submitdate>12/03/2010</submitdate>
  <approvaldate>16/03/2010</approvaldate>
  <actrnumber>ACTRN12610000212055</actrnumber>
  <trial_identification>
    <studytitle>The effects of omega-3 fatty acid (docosahexaenoic acid) supplementation on cognitive performance in healthy adults.</studytitle>
    <scientifictitle>Effects of a high docosahexaenoic acid (DHA) fatty acid supplement on cognitive performance in healthy adults</scientifictitle>
    <utrn>U1111-1114-4016</utrn>
    <trialacronym />
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Cognitive performance</healthcondition>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Studies of normal psychology, cognitive function and behaviour</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>3 capsules per day for 6 months to be consumed orally of docosahexaenoic fatty acid supplement (providing 1.124 mg of docosahexaenoic acid/day)</interventions>
    <comparator>3 capsules per day for 6 months to be consumed orally of high oleic acid sunflower oil (2.25g/day)</comparator>
    <control>Active</control>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Cognitive performance using a battery of computer based tests including: working memory (N-Back, Corsi Blocks, Letter-number sequencing task); Long-term memory (Immediate and delayed work recall, Immediate and delayed word recognition, Immediate and delayed picture recognition); Processing spead / reaction time (Finding A's, Simple reaction time, Choice reaction time); Attention (Stroop test); Sustained attention task (Digit vigilance)</outcome>
      <timepoint>Baseline, 6 months</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Interaction of apo E genotype assessed by extracting deoxyribonucleic acid (DNA) from a blood sample and using standard laboraotry based tests.</outcome>
      <timepoint>6 months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Healthy men and women 18-45 years</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>45</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>High habitual intake of fatty fish (&gt;1 serving/month)
Consuming fish oil supplements
Smokers
Allergies to seafood
Pregnant or lactating</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>The person who will determine if a subject is eligible for inclusion in the trial will be unaware, when this decision is made, to which group the subjects will be allocated. 
Allocation will be done by central randomisation by computer.</concealment>
    <sequence>Eligible subjects will be randomly assigned to the docosahexaenoic acid (DHA) supplement or placebo using computer generated random numbers tables.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1>True</masking1>
    <masking2>True</masking2>
    <masking3>True</masking3>
    <masking4>True</masking4>
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>14/04/2010</anticipatedstartdate>
    <actualstartdate>30/03/2010</actualstartdate>
    <anticipatedenddate />
    <actualenddate>4/05/2010</actualenddate>
    <samplesize>200</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Massey University</primarysponsorname>
    <primarysponsoraddress>Administrator University Research Committee
Massey University
Palmerston North
4442</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Massey University Research Fund (MURF)</fundingname>
      <fundingaddress>Administrator University Research Committee
Massey University
Palmerston North
4442</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Neurological Foundation of New Zealand</fundingname>
      <fundingaddress>PO Box 110022
Auckland 1148
</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Oakley Mental Health Research</fundingname>
      <fundingaddress>Oakley Mental Health Research Foundation
PO Box 68323
Newton
AUCKLAND 1145
</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Commercial sector/Industry</sponsortype>
      <sponsorname>Efamol Ltd</sponsorname>
      <sponsoraddress>14 Mole Business Park
Leatherhead
Surrey
KT22 7BA</sponsoraddress>
      <sponsorcountry>United Kingdom</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>To investigate whether a high DHA fatty acid supplement will improve cognitive performance tasks in 200 healthy adults over a period of 6 months using a  randomised placebo controlled double blind study design.</summary>
    <trialwebsite>None</trialwebsite>
    <publication>Stonehouse W, Conlon CA, Podd J, Hill, SR, Minihane AM, Haskell C, Kennedy D. Docosahexaenoic acid supplementation improved both memory and reaction time in healthy young adults: A randomized controlled trial. Am J Clin Nutr. 2013 May;97(5):1134-43. doi: 10.3945/ajcn.112.053371. Epub 2013 Mar 20. PMID: 23515006.</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Massey University Human Ethics Committee (MUHEC): Southern A</ethicname>
      <ethicaddress>Research Ethics Office
Massey University
Palmerston North
4442</ethicaddress>
      <ethicapprovaldate>10/03/2010</ethicapprovaldate>
      <hrec>MUHEC: Southern A application 10/07</hrec>
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Welma Stonehouse</name>
      <address>CSIRO Animal, Food and Health Sciences, PO Box 10041 Adelaide BC, South Australia, Australia, 5000</address>
      <phone>+61 8 8303 8919 </phone>
      <fax>+61 8 8303 8899 </fax>
      <email>welma.stonehouse@csiro.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Cath Conlon</name>
      <address>Institute of Food Nutrition and Human Health
Massey University
Private Bag 102904
North Shore City
0745
Auckland</address>
      <phone>+64 9 443 9748</phone>
      <fax>+64 9 414 9640</fax>
      <email>c.conlon@massey.ac.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Welma Stonehouse</name>
      <address>CSIRO Animal, Food and Health Sciences, PO Box 10041 Adelaide BC, South Australia, Australia, 5000</address>
      <phone>+61 8 8303 8919 </phone>
      <fax>+61 8 8303 8899 </fax>
      <email>welma.stonehouse@csiro.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Welma Stonehouse</name>
      <address>CSIRO Animal, Food and Health Sciences, PO Box 10041 Adelaide BC, South Australia, Australia, 5000</address>
      <phone>+61 8 8303 8919 </phone>
      <fax>+61 8 8303 8899 </fax>
      <email>welma.stonehouse@csiro.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>